Giant cutaneous pseudolymphoma
Ismail Essadi, Issam Lalya
Corresponding author: Ismail Essadi, Medical Oncology Department, Avicenne Military Hospital, Cadi Ayyad University Marrakech, Marrakech, Morocco
Received: 21 May 2020 - Accepted: 27 May 2020 - Published: 28 May 2020
Domain: Dermatology,Oncology
Keywords: Pseudolymphoma, etiological investigation, steroids infiltration
©Ismail Essadi et al. PAMJ Clinical Medicine (ISSN: 2707-2797). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Cite this article: Ismail Essadi et al. Giant cutaneous pseudolymphoma. PAMJ Clinical Medicine. 2020;3:33. [doi: 10.11604/pamj-cm.2020.3.33.23670]
Available online at: https://www.clinical-medicine.panafrican-med-journal.com//content/article/3/33/full
Giant cutaneous pseudolymphoma
Ismail Essadi1,&, Issam Lalya2
1Medical Oncology Department, Avicenne Military Hospital, Cadi Ayyad University Marrakech, Marrakech, Morocco, 2Radiation Oncology Department, Mohammed VI Oncology Hematology Hospital, Cadi Ayyad University, Marrakech, Morocco
&Corresponding author
Ismail Essadi, Medical Oncology Department, Avicenne Military Hospital, Cadi Ayyad University Marrakech, Marrakech, Morocco
A 53-year-old male without significant medical history, presented to our department with a giant tumor mass of the left interscapular region measuring 25 X 13cm. Physical exam had found a multilobulated mass fixed to the deep plane, with cutaneous infiltration and bluish aspect of the skin covering the mass (A). CT scan of the interscapular region showed a mass of 25cm long axis without evidence of invasion of the muscular plane. A skin biopsy with histopathological and immunohistochemical study have established the diagnosis of a cutaneous pseudolymphoma. An extension workup allowed to rule out the presence of other lesions. A thorough etiological investigation was conducted, including viral serologies (HIV, hepatitis, herpes), a serology of lyme borreliosis and search for a drug-taking antecedent or skin tattoos in the affected area. All the explorations proved to be negative. We opted for an infiltration of the mass by steroids. The patient received two infiltrations with methylprednisolone acetate at 160mg each, with an interval of 3 weeks. We noted a complete disappearance of the mass 6 weeks after the first infiltration. The skin has recovered a normal color (B).Cutaneous pseudolymphoma is a benign entity. It occurs most often in the form of localized nodule with modification of the color of the skin. The diagnosis may be clinically suspected, but can only be confirmed through a biopsy with histopathological and immunohistochemistry. Therapeutic options vary between topical steroids or infiltrations, surgical resection or radiotherapy in some cases.
Figure 1: (A) giant cutaneous pseudolymphoma; (B) good clinical response after steroids infiltrations